BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23564786)

  • 1. Salinomycin induces apoptosis via death receptor-5 up-regulation in cisplatin-resistant ovarian cancer cells.
    Parajuli B; Shin SJ; Kwon SH; Cha SD; Chung R; Park WJ; Lee HG; Cho CH
    Anticancer Res; 2013 Apr; 33(4):1457-62. PubMed ID: 23564786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells.
    Parajuli B; Lee HG; Kwon SH; Cha SD; Shin SJ; Lee GH; Bae I; Cho CH
    Cancer Epidemiol; 2013 Aug; 37(4):512-7. PubMed ID: 23545383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
    Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
    Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
    Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
    Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
    Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between expression of apoptosis-associated proteins and caspase-3 activity in cisplatin-resistant human ovarian cancer cell line].
    Yang XK; Zheng F; Chen JH; Gao QL; Lu YP; Wang SX; Wang CY; Ma D
    Ai Zheng; 2002 Dec; 21(12):1288-91. PubMed ID: 12520732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
    Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1.
    Chauhan P; Sodhi A; Tarang S
    Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.
    Su L; Liu G; Hao X; Zhong N; Zhong D; Liu X; Singhal S
    Eur J Cancer; 2011 Nov; 47(16):2471-8. PubMed ID: 21726997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
    Abedini MR; Qiu Q; Yan X; Tsang BK
    Oncogene; 2004 Sep; 23(42):6997-7004. PubMed ID: 15258564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P; Sun NK; Chao CC
    Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.